Madrigal Pharmaceuticals (United States)
- Research works
- 51 ▲ 449% vs 2013–17
- Citations
- 447 8.8 per fractional work
- Top-10% rate
- 11.0% record average 16.5%
- Open access
- 55% world 28%
Not ranked overall: Madrigal Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
What does Madrigal Pharmaceuticals (United States) specialise in?
Where its research is concentrated relative to its size: Medicine takes 4.5× the share of its output that it takes of world research.
- MedicineField · 32.3 works4.5×
- Health SciencesDomain · 32.7 works3.8×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 5.6×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 5.6×
- Medicine 4.5×
- Nursing 1.8×
- Chemistry 1.2×
- Biochemistry, Genetics and Molecular Biology 0.8×
- Economics, Econometrics and Finance 0.8×
- Business, Management and Accounting 0.3×
- Immunology and Microbiology 0.2×
- Health Professions 0.1×
- Computer Science 0.1×
- Neuroscience 0.1×
- Social Sciences 0.1×
- Decision Sciences 0.1×
- Engineering 0.0×
Which keywords describe research at Madrigal Pharmaceuticals (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Metabolic Syndrome, Insulin Resistance, Hepatic Steatosis, Hepatocellular Carcinoma, NAFLD, NASH, Inflammation and Cardiovascular Disease.
- Metabolic Surgery
- Folate
- Genetic Polymorphisms
- Cardiovascular Risk
- Heart Failure
- Cholesterol
- Management
- Hepatic Stellate Cells
- Type 2 Diabetes
- Hepatic Encephalopathy
- Fructose
- Atherosclerosis
- Low-Carbohydrate Diet
- Epidemiology
- Oxidative Stress
- Weight Loss
- Cardiovascular Disease
- NASH
- Hepatocellular Carcinoma
- Insulin Resistance
- Metabolic Syndrome
- Hepatic Steatosis
- NAFLD
- Inflammation
- Obesity
- Glucose Metabolism
- Diabetes
- Ketogenic Diet
- Lifestyle Intervention
- Diagnosis
- Hypertension
- Liver Cirrhosis
- Treatment
- Liver Regeneration
- Liver Transplantation
- Global Prevalence
- Pathogenesis
- Cognitive Impairment
- Bariatric Surgery
- Homocysteine
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Metabolic Syndrome18▲ 59×5 topics
- Insulin Resistance15▲ 89×5 topics
- Hepatic Steatosis14▲ 242×2 topics
- Hepatocellular Carcinoma12▲ 156×2 topics
- NAFLD12▲ 271×1 topic
- NASH12▲ 271×1 topic
- Inflammation7▲ 9.1×13 topics
- Cardiovascular Disease6▲ 13×6 topics
- Obesity5▲ 17×5 topics
- Weight Loss3▲ 54×2 topics
- Glucose Metabolism3▲ 83×2 topics
- Oxidative Stress3▲ 4.8×5 topics
- Diabetes2▲ 13×3 topics
- Epidemiology2▲ 1.54×10 topics
- Ketogenic Diet2▲ 64×1 topic
- Low-Carbohydrate Diet2▲ 71×1 topic
- Lifestyle Intervention2▲ 69×2 topics
- Atherosclerosis2▲ 19×2 topics
- Diagnosis2▲ 5.5×6 topics
- Fructose2▲ 142×1 topic
- Hypertension2▲ 17×1 topic
- Hepatic Encephalopathy2▲ 84×1 topic
- Liver Cirrhosis2▲ 84×1 topic
- Type 2 Diabetes2▲ 21×2 topics
- Treatment2▲ 3.4×5 topics
- Hepatic Stellate Cells2▲ 242×1 topic
- Liver Regeneration2▲ 242×1 topic
- Management1▲ 4.8×5 topics
- Liver Transplantation1▲ 28×2 topics
- Cholesterol1▲ 23×1 topic
- Global Prevalence1▲ 36×1 topic
- Heart Failure1▲ 7.4×2 topics
- Pathogenesis1▲ 6.0×4 topics
- Cardiovascular Risk1▲ 9.4×2 topics
- Cognitive Impairment1▲ 12×2 topics
- Genetic Polymorphisms1▲ 54×2 topics
- Bariatric Surgery1▲ 81×1 topic
- Folate1▲ 97×1 topic
- Homocysteine1▲ 97×1 topic
- Metabolic Surgery1▲ 81×1 topic
Which research topics does Madrigal Pharmaceuticals (United States) publish most on?
By volume in 2022–2025: Liver Disease Diagnosis and Treatment, Diet and metabolism studies, Diet, Metabolism, and Disease and Liver Disease and Transplantation.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Liver Disease Diagnosis and Treatment Epidemiology 12 works
- 2 Diet and metabolism studies Physiology 2 works
- 3 Diet, Metabolism, and Disease Endocrinology, Diabetes and Metabolism 2 works
- 4 Liver Disease and Transplantation Hepatology 2 works
- 5 Liver physiology and pathology Hepatology 2 works
- 6 Diabetes, Cardiovascular Risks, and Lipoproteins Endocrinology, Diabetes and Metabolism 1 works
- 7 Bariatric Surgery and Outcomes Surgery 1 works
- 8 Folate and B Vitamins Research Rheumatology 1 works
- 9 Cardiovascular Disease and Adiposity Cardiology and Cardiovascular Medicine 1 works
- 10 Antiplatelet Therapy and Cardiovascular Diseases Cardiology and Cardiovascular Medicine 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Madrigal Pharmaceuticals (United States)'s research output changed?
Output in 2018–2022 was 449% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in West Conshohocken
- American Society For Testing and Materials
- Macula Vision Research Foundation
- John Templeton Foundation
- Telefactor Robotics (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.